A. B. Sahin Et Al. , "Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment," Oncology Letters , vol.26, no.6, 2023
Sahin, A. B. Et Al. 2023. Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment. Oncology Letters , vol.26, no.6 .
Sahin, A. B., CANER, B., Ocak, B., Gulmez, A., HAMİTOĞLU, B., ÇUBUKÇU, E., ... DELİGÖNÜL, A.(2023). Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment. Oncology Letters , vol.26, no.6.
Sahin, Ahmet Et Al. "Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment," Oncology Letters , vol.26, no.6, 2023
Sahin, Ahmet B. Et Al. "Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment." Oncology Letters , vol.26, no.6, 2023
Sahin, A. B. Et Al. (2023) . "Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment." Oncology Letters , vol.26, no.6.
@article{article, author={Ahmet Bilgehan Sahin Et Al. }, title={Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment}, journal={Oncology Letters}, year=2023}